Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits

Toxicon

Volumn 50, Issue 2, 2007, Pages 180-188

  Chen, Shih Ming ^a   Fan, Mei Yu ^a   Tseng, Chia Chi ^a   Ho, Yih ^a   Hsu, Kuang Yang ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aristolochic acids nephropathy (AAN); Nephrotoxicity; Pharmacokinetic; Rabbit

Indexed keywords

ARISTOLOCHIC ACID;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARISTOLOCHIA; ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY TUBULE DAMAGE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ARISTOLOCHIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY DISEASES; MALE; RABBITS;

ARISTOLOCHIA; ORYCTOLAGUS CUNICULUS;

EID: 34447260866     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2007.03.011     Document Type: Article

References (26)

1. Arlt V.M., Pfohl-Leszkowicz A., Cosyns J., and Schmeiser H.H. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat. Res. 494 (2001) 143-150
2. Arlt V.M., Stiborova M., and Schmeiser H.H. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17 (2002) 265-277
3. Cosyns J.P., Dehoux J.P., Guiot Y., Goebbels R.M., Robert A., Bernard A.M., and van Ypersele de Strihou C. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?. Kidney Int. 59 (2001) 2164-2173
4. Hashimoto K., Higuchi M.B., Makino I., Sakakibara M., Kubo Y., Komatsu M., Maruno M., and Okada M. Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. J. Ethnopharmacol. 64 (1999) 185-189
5. Hong Y.T., Fu L.S., Chung L.H., Hung S.C., Huang Y.T., and Chi C.S. Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs. Pediatr. Nephrol. 21 (2006) 577-579
6. Ioset J.R., Raoelison G.E., and Hostettmann K. Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem. Toxicol. 41 (2003) 29-36
7. Krumbiegel G., Hallensleben J., Mennicke W.H., Rittmann N., and Roth H.J. Studies on the metabolism of aristolochic acids I and II. Xenobiotica 17 (1987) 981-991
8. Lee S., Lee T., Lee B., Choi H., Yang M., Ihm C.-G.., and Kim M. Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. Nephrology 9 (2004) 126-129
9. Li Y., Liu Z., Guo X., Shu J., Chen Z., and Li L. Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro. Arch. Toxicol. 80 (2006) 524-532
10. Liu M.-C., Maruyama S., Mizuno M., Morita Y., Hanaki S., Yuzawa Y., and Matsuo S. The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids. Clin. Exp. Nephrol. 7 (2003) 186-194
11. Mengs U. On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch. Toxicol. 52 (1983) 209-220
12. Mengs U. Acute toxicity of aristolochic acid in rodents. Arch. Toxicol. 59 (1987) 328-331
13. Mengs U. Tumour induction in mice following exposure to aristolochic acid. Arch. Toxicol. 61 (1988) 504-505
14. Mengs U., and Stotzem C.D. Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology. Arch. Toxicol. 67 (1993) 307-311
15. Ong E.S., Woo S.O., and Yong Y.L. Pressurized liquid extraction of berberine and aristolochic acids in medicinal plants. J. Chromatogr. A 904 (2000) 57-64
16. Sato N., Takahashi D., Chen S.-M., Tsuchiya R., Mukoyama T., Yamagata S., Ogawa M., Yoshida M., Kondo S., Satoh N., and Ueda S. Acute nephrotoxicity of aristolochic acids in mice. J. Pharm. Pharmacol. 56 (2004) 221-229
17. Schmeiser H.H., Schoepe K.B., and Wiessler M. DNA adduct formation of aristolochic acid I and II in vitro and in vivo. Carcinogenesis 9 (1988) 297-303
18. Schmeiser H.H., Bieler C.A., Wiessler M., van Ypersele de Strihou C., and Cosyns J.P. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res. 56 (1996) 2025-2028
19. Shah V.P., Midha K.K., Dighe S.V., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., and Spector S. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm. Res. 9 (1992) 588-592
20. Shumaker R.C. PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab. Rev. 17 (1986) 331-348
21. Su T., Qu L., Zhang C.-L., Cai S.-Q., and Li X.-M. Studies on pharmacodynamic characteristics of aristolochic acid I in rats. China journal of Chinese Materia Medica 29 (2004) 676-681
22. Tsai T.H., Chou C.J., Lin L.C., Tsai W.J., and Chen C.F. Determination of aristolochic acid in rabbit plasma by high-performance liquid chromatography with photodiode-array ultraviolet detection and its pharmacokinetics application. J. Liq. Chromatogr. 16 (1993) 1173-1182
23. Vanhaelen M., Vanhaelen-Fastre R., But P., and Vanherweghem J.L. Identification of aristolochic acid in Chinese herbs. Lancet 343 (1994) 174
24. Vanherweghem J.L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., Richard C., Vandervelde D., Verbeelen D., Vanhaelen-Fastre R., and Vanhalen M. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341 (1993) 387-391
25. Wang G., Wang Z.-M., and Sun Q.-S. Advances in studies on pharmacokinetics of aristolochic acid I. China journal of Chinese Materia Medica 31 (2006) 1573-1575
26. Ye Z.B., Zhang Y., and Wu Z.L. Pharmacokinetic investigation of aristolochic acid A in normal rats. Fudan Univ. J. Med. Sci. 31 (2004) 562-564